Our results indicated that monocytes and globulin are risk factors while pre-albumin (PALB) is protective after selected by Lasso, RSF and multivariate Cox regression, providing a robust tool for predicting overall survival and guiding treatment for high-risk HCC patients. This evidence concerns the gene ALB and hepatocellular carcinoma.